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http://www.microbialcellfactories.com/content/11/1/138RESEARCH Open AccessMetabolic engineering of the purine biosynthetic
pathway in Corynebacterium glutamicum results
in increased intracellular pool sizes of IMP
and hypoxanthine
Susanne Peifer1, Tobias Barduhn1, Sarah Zimmet1, Dietrich A Volmer2, Elmar Heinzle1 and Konstantin Schneider1*Abstract
Background: Purine nucleotides exhibit various functions in cellular metabolism. Besides serving as building blocks
for nucleic acid synthesis, they participate in signaling pathways and energy metabolism. Further, IMP and GMP
represent industrially relevant biotechnological products used as flavor enhancing additives in food industry.
Therefore, this work aimed towards the accumulation of IMP applying targeted genetic engineering of
Corynebacterium glutamicum.
Results: Blocking of the degrading reactions towards AMP and GMP lead to a 45-fold increased intracellular IMP
pool of 22 μmol gCDW-1 . Deletion of the pgi gene encoding glucose 6-phosphate isomerase in combination with
the deactivated AMP and GMP generating reactions, however, resulted in significantly decreased IMP pools
(13 μmol gCDW-1 ). Targeted metabolite profiling of the purine biosynthetic pathway further revealed a metabolite
shift towards the formation of the corresponding nucleobase hypoxanthine (102 μmol gCDW-1 ) derived from IMP
degradation.
Conclusions: The purine biosynthetic pathway is strongly interconnected with various parts of the central
metabolism and therefore tightly controlled. However, deleting degrading reactions from IMP to AMP and GMP
significantly increased intracellular IMP levels. Due to the complexity of this pathway further degradation from IMP
to the corresponding nucleobase drastically increased suggesting additional targets for future strain optimization.
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Metabolic flux analysisBackground
The diverse class of purine intermediates comprises
phosphorylated nucleotides, nucleosides and nucleo-
bases, exhibiting multiple functions in the cellular sys-
tem [1]: for example, they serve as transmitters of the
genetic information [2], as phosphate group donors, are
involved in signal mediation [3] and ensure the energy
supply of the living cell [4]. Thus, these intermediates
are involved in almost every aspect of cellular metabol-
ism. Furthermore, some of these compounds possess* Correspondence: ko.schneider@mx.uni-saarland.de
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reproduction in any medium, provided the orsecondary functions as flavor enhancing substances, i.e.
IMP and GMP [5-7], and act as potential drugs in med-
ical therapy, e.g. inosine and purine analogs [8-10]. Due
to their immense pharmaceutical and biotechnological
potential, these compounds have been successfully
synthesized over the past decades via fermentative pro-
duction employing Corynebacteria, especially Coryne-
bacterium ammoniagenes [11-13].
Their de novo synthesis, however, is energetically ex-
pensive and imbalances in their pool sizes are reported
to be directly linked to increased mutation rates [14],
which eventually leads to constant pool sizes [2]. These
are maintained by a balanced system with two compen-
satory operating parts: the de novo biosynthesis pathway,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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metabolism, and the salvage pathway, which can replen-
ish corresponding pools (Figure 1) [6,7,10,15].
De novo nucleotide synthesis begins with the activation
of the pentose phosphate pathway (PPP) intermediate
and direct precursor ribose 5-phosphate [16], which is
further converted to IMP in a twelve-step biosynthetic
process with concomitant consumption of 10 mol ATP.
AMP and GMP are derived from IMP as depicted in
Figure 1 [1,17]. The salvage pathway, however, converts
extracellular nucleobases or degraded purine compounds
into the corresponding nucleosides and nucleotides
[11,18], thereby preventing energetically expensive de
novo synthesis of these compounds.
Since primary metabolism is designed and optimized to
deliver and sustain a more or less consistent distribution
of metabolites (described as network rigidity [19]) –
which can be used as cellular building blocks, redox
equivalents, energy and co-factors – any kind of overpro-
duction or accumulation basically targets the deregulation
of the underlying metabolism. In the present study, a
strategy for increased IMP accumulation was developed
by focusing on modifying the general key factors for over-
production: (i) increasing the precursor availability; (ii)
de-bottlenecking regulation-restricted branch points, and
(iii) deactivating the depleting reactions. The goal of this
study was to identify essential nodes of this pathway and
to uncover impacts from central and purine metabolism.Figure 1 Metabolic map of the purine biosynthetic pathway. Dashed
contributing enzymes of de novo biosynthetic pathway (dark gray) an
inhibition of the rate controlling step of the purine biosynthetic pathway, r
stringent inhibitors GMP and AMP based on Zhou et al. [38]. Abbreviation
IMP, inosine 5-monophosphate; AMP, adenosine 5-monophosphate; XMP
purA, adenylosuccinate synthetase; purB, adenylosuccinate lyase; guaB2, IM
phosphoribosyltransferase; hpt, hypoxanthine-guanine phosphoribosyltransApplying genetic engineering and in-depth metabolome
analysis of the purine pathway intermediates, informa-
tion of the extremely well-regulated purine pathway
should be gathered [1,17,20,21]. However, the under-
lying mechanisms and the contributions of different
branches are not well described yet. In addition, identi-
fication of individual regulation factors [22,23] operat-
ing at different hierarchic levels [24] is challenging due
to the comprehensive connectivity of the metabolic net-
work. The interconnectivity of metabolome and fluxome
therefore provides valuable insights into global dynamics
[25,26] resulting from single and multiple perturbations
in the central and branch metabolism [27].Results
Metabolic snapshots of the purine pathway in wild type
C. glutamicum
Intracellular metabolite concentrations in C. glutamicum
were quantified after whole culture extraction using LC-
ESI-MS/MS [28]. In order to verify balanced growth
conditions [29,30] and stable intracellular metabolite
concentrations [31,32], respectively, quantification was
performed for two different biomass concentrations,
resulting in four biological replicates for each biomass
concentration. The corresponding concentrations of
nucleotides, nucleosides and nucleobases related to the
cell dry weight are listed in Table 1.lines indicate multiple enzymatic steps; boxes denote
d salvage pathway (light gray). Red lines indicate feedback
egulating the activity of the PRPP amidotransferase by the most
s: R5P, ribose 5-phosphate; PRPP, 5-phosphoribosyl 1-pyrophosphate;
xanthosine 5-monophosphate; GMP, guanosine 5-monophosphate;
P dehydrogenase; guaA, GMP synthase; apt, adenine
ferase.
Table 1 Concentrations of purine intermediates [μmol gCDW
-1 ] determined for C. glutamicum wild type (ATCC 13032) and
site-directed mutantsa
Compound Concentration [μmol gCDW
-1 ]
ATCC 13032 Δpgi purFK348Q ΔpurAc ΔguaB2c ΔpurA ΔguaB2 ΔpurA ΔguaB2
purFK348Q Δpgi
AMP 8.13 ± 0.50 9.07 ± 0.52 10.24 ± 0.78 10.66 (17.93) ± 0.22 (1.18) 10.11 (27.79) ± 0.05 (2.03) 3.69 ± 0.54 3.57 ± 0.20
adenosine 0.10 ± 0.01 0.09 ± 0.01 0.12 ± 0.02 0.13 ± 0.01 0.21 ± 0.01 0.05 ± 0.00 0.15 ± 0.03
adenine 2.63 ± 0.25 3.04 ± 0.11 3.36 ± 0.30 3.04 (5.58) ± 0.38 (0.26) 4.03 (8.32) ± 0.13 (0.53) b b
GMP 2.63 ± 0.16 3.65 ± 0.17 4.75 ± 0.27 9.47 (21.10) ± 0.12 (2.03) 3.92 (2.33) ± 0.19 (0.24) 0.65 ± 0.07 0.51 ± 0.03
guanosine 0.04 ± 0.00 b 0.03 ± 0.00 0.03 ± 0.01 0.06 ± 0.01 0.10 ± 0.01 0.23 ± 0.02
guanine 3.27 ± 0.28 3.85 ± 0.17 5.08 ± 0.61 5.07 (10.27) ± 1.45 (0.62) 35.67 (9.38) ± 1.65 (0.64) b b
IMP 0.49 ± 0.06 0.42 ± 0.03 0.55 ± 0.05 30.72 (43.99) ± 0.48 (3.32) 6.39 (37.16) ± 0.21 (3.48) 21.91 ± 0.89 12.88 ± 0.74
inosine 0.13 ± 0.05 0.21 ± 0.04 0.38 ± 0.12 0.28 ± 0.06 0.85 ± 0.06 1.26 ± 0.08 2.53 ± 0.19
hypoxanthine 0.28 ± 0.03 0.29 ± 0.03 0.28 ± 0.03 11.87 (17.92) ± 1.00 (1.26) 3.55 (16.19) ± 0.04 (1.34) 80.65± 3.19 101.53 ± 1.09
XMP b b b b n. d. n. d. n. d.
xanthosine b b b b n. d. n. d. n. d.
xanthine 0.12 ± 0.01 0.22 ± 0.01 0.11 ± 0.00 0.17 ± 0.00 n. d. n. d. n. d.
a Concentrations and corresponding standard deviations were determined using 4 biological replicates for each compound and standardized to the cell dry
weight.
b Below detection limit.
c Purine intermediate concentrations determined for C. glutamicum ΔpurA and C. glutamicum ΔguaB2 represent maximum values obtained for two biomass
concentrations for each strain: numbers on top correspond to the first biomass concentration (1.3 g L-1 for C. glutamicum ΔpurA and 1.1 g L-1 for C. glutamicum
ΔguaB2) and numbers in brackets for second biomass concentration (1.9 g L-1 for C. glutamicum ΔpurA and 1.8 g L-1 for C. glutamicum ΔguaB2).
n. d. not detected.
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below the detection limit, were quantified with a precision
better than 12%. AMP and GMP, as central building con-
stituents for DNA and RNA and co-substrates for various
enzyme reactions [2,3], showed the highest concentration
ranges of 8.13 and 2.63 μmol gCDW
-1 , respectively. Other
intermediates varied within a broader concentration
range from 0.04 to 3.27 μmol gCDW
-1 . The lowest concen-
trations were detected for nucleosides reaching up to
0.04 μmol gCDW
-1 for guanosine.
Several genetic perturbations aiming at various meta-
bolic key nodes were performed to evaluate the effects
and impacts of changing activities of different metabolic
branches of the metabolism on the intracellular purine
pool sizes.
Manipulating the main carbon flux distribution
The first implemented modification affected the glucose
6-phosphate branch point and focused on amending the
availability of the immediate precursor of IMP, ribose 5-
phosphate. The carbon flux distribution was rerouted by
deleting the first enzyme of the glycolysis, the glucose 6-
phosphate isomerase encoded by the pgi gene, resulting
in an entry block into glycolysis at that stage and thus
restricting the metabolization of glucose 6-phosphate ex-
clusively by the PPP. Growth parameters are depicted in
Table 2. The specific growth rate of C. glutamicum Δpgi
was slightly reduced compared to the wild type strain, as
was biomass formation.Phenotypic analysis was further extended towards the
determination of free intracellular purine pool sizes and
a metabolic profile based on these analyses was gener-
ated (Table 1). Intracellular concentrations related to cell
dry weight showed only minor changes compared to
wild type C. glutamicum. GMP and AMP concentrations
were slightly increased in C. glutamicum Δpgi, as were
amounts of adenine, guanine and inosine. Adenosine
and guanosine showed decreased concentrations. IMP
and hypoxanthine were not affected significantly.
Targeted perturbations of the purine biosynthetic
pathway
Further genetic manipulations aimed at the purine path-
way itself, to estimate immediate effects emanating from
this metabolic branch. The first target was the purF gene
encoding the PRPP amidotransferase. This enzyme is
generally regarded to act as key controller in the purine
de novo synthesis, regulated by a feedback inhibition
mainly caused by GMP and AMP [7,33]. An experimen-
tally identified amino acid substitution (K326Q) in the
purF gene is reported to offset this feedback inhibition
by AMP and GMP in E. coli [34] and was incorporated
into the corresponding position in the purF gene of C.
glutamicum. In order to check for evolutionary con-
served coding regions, a sequence alignment covering
the complete amino acid sequence was performed [34].
Therefore, six organisms exhibiting a broad phylogenetic
distinction, including Escherichia coli, Corynebacterium
Table 2 Growth parameters for C. glutamicum ATCC
13032 and site-directed mutants
Strain Parameter
μ Yx/s qS
ATCC 13032 0.443 ± 0.004 0.095 ± 0.004 4.67 ± 0.09
Δpgi 0.376 ± 0.001 0.090 ± 0.002 4.18 ± 0.02
purFK348Q 0.440 ± 0.008 0.091 ± 0.001 4.82 ± 0.06
ΔpurA 0.455 ± 0.006 0.090 ± 0.001 5.05 ± 0.02
ΔguaB2 0.320 ± 0.007 0.073 ± 0.004 4.38 ± 0.03
ΔpurA ΔguaB2 0.317 ± 0.006 0.075 ± 0.001 4.24 ± 0.01
ΔpurA ΔguaB2
purFK348Q Δpgi
0.146 ± 0.003 0.076 ± 0.003 1.92 ± 0.02
Given data represent mean values obtained from two parallel cultivations with
corresponding standard deviations: specific growth rate (μ) [h-1]; biomass yield
(YX/S) [g mmol
-1] and the specific glucose consumption rate (qS) [mmol g
-1 h-1].
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subtilis, Salmonella typhimurium and Saccharomyces
cerevisiae, were analyzed. A conserved region compris-
ing at least ten amino acids was identified for all organ-
isms including the identified location of the amino acid
substitution K326Q in E. coli described by Zhou et al.
[34]. The corresponding substitution K348Q in C. gluta-
micum was inserted into the genomic DNA. Verification
of the base exchange was carried out by sequencing.
The amino acid substituent C. glutamicum purFK348Q
(purFK348Q) showed balanced growth with stable biomass
formation and growth rate (Table 2). Intracellular purine
intermediate pool sizes remained almost unchanged for
adenosine, guanosine and hypoxanthine (Table 1). The
most striking changes were observed for intracellular in-
osine concentration which increased 2.9-fold. Compared
to the wild type strain, the IMP concentration, however,
showed only a minor change (10% increase). Intracellular
concentrations of AMP and its corresponding nucleobase
adenine increased by approximately 25% each. GMP and
guanine pool sizes in C. glutamicum purFK348Q increased
significantly by 80% and 55%, respectively, compared to
the wild type, indicating a global shift towards the main
intermediates GMP, AMP and inosine. Direct determin-
ation of the in vitro activity of PurF following the method
of Matsui et al. [35], employing HPLC quantitation of
substrate (glutamine) and product (glutamate) concentra-
tions [36] over time in crude cell extracts, resulted in tre-
mendous background activity, not permitting kinetic
studies. In addition, heterologous expression using
Escherichia coli as expression system resulted in enzyme
inactivation, probably due to complex posttranslational
events. Further studies will however focus on the deter-
mination of the in vitro activity.
In addition to the deregulation of PurF, further genetic
manipulations aimed at IMP degradation, affecting the syn-
thesis of IMP-derived GMP and AMP. The biosynthesis ofboth intermediates was thus shifted from de novo biosyn-
thesis to the purine salvage pathway, employing the two
enzymes adenosine-phosphoribosyltransferase (APRT) and
hypoxanthine-guanine-phosphoribosyltransferase (HGPRT)
catalyzing the synthesis of AMP and GMP/IMP via a con-
densing reaction of adenine and guanine/hypoxanthine
with PRPP maintaining a sustained supply of the necessary
precursors. These genetic manipulations, however, lead to
auxotrophies for adenine and/or guanine [35,37].
As initial strategy, the single gene deletions of the
adenylosuccinate synthetase (purA) (catalyzing the con-
version of IMP to AMP) and of the IMP-dehydrogenase
(guaB2) (catalyzing the reaction of IMP to GMP) were
analyzed. Due to the generated auxotrophies, the medium
had to be supplied with adenine and guanine and resulting
phenotypes based on intracellular concentrations of
the corresponding purine pathway intermediates were
analyzed (Table 1).
The metabolic shift from de novo purine biosynthesis
to the salvage pathway did not show any significant
changes in the growth rate of the purA deletion strain.
The guaB2 deletion strain, however, showed a drastic
response after redirecting GMP formation to the sal-
vage pathway: biomass yield was reduced by 25%
(0.073 g mol-1glucose) of the wild type yield and the spe-
cific growth rate even dropped by 30% of the wild type
rate, reaching a stable rate of 0.32 h-1, thus indicating a
restricted compensation efficiency of the salvage path-
way concerning the GMP supply. Metabolic phenotyping
revealed even more distinct alterations: most strikingly
both deletion mutants were characterized by unbalanced
intracellular pools sizes, exhibiting transient concentra-
tion changes which could not be related to biomass for-
mation (Table 1). Degradation inefficiency of IMP
towards the following nucleotides (GMP and AMP) led
to maximal intracellular IMP concentrations of 44 μmol
gCDW
-1 (ΔpurA) and 37 μmol gCDW
-1 (ΔguaB2) correspond-
ing to a 90- and 80-fold increase compared to the wild
type strain. Hypoxanthine concentrations were affected
likewise.
The unbalanced metabolic state observed in C. gluta-
micum ΔpurA and C. glutamicum ΔguaB2, was further
investigated in the double deletion mutant C. glutamicum
ΔpurA ΔguaB2, exhibiting auxotrophies for adenine as well
as for guanine. Specific growth parameters of the double
deletion mutant, i.e. biomass yield (0.075 gCDW mmolglucose
-1 )
and specific growth rate (0.317 h-1), were consistent with
those obtained for C. glutamicum ΔguaB2, indicating a
mutual growth-related effect. However, the metabolic
fingerprint for C. glutamicum ΔpurA ΔguaB2 exhibited
remarkable differences (Table 1): the unbalanced meta-
bolic behavior observed in C. glutamicum ΔpurA and C.
glutamicum ΔguaB2 was completely reestablished result-
ing in constant intracellular purine intermediate
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deletion mutant showed a decreased intracellular IMP
pool of 21.9 μmol gCDW
-1 compared to the single gene de-
letion mutants which corresponds to a 44-fold increase
compared to the wild type strain. The IMP reduction was
accompanied by a significant increase of the inosine con-
centration (9.7-fold compared to the wild type strain)
and especially hypoxanthine (290-fold compared to the
wild type strain), indicating a metabolic shift from main
purine intermediates; i.e., the nucleotides, to the corre-
sponding degradation products (nucleobases).
Extended metabolic manipulations – combination of
central pathway and branch pathway modifications
Finally, the combined influence of the genetic modifications
described above was investigated. The rationally designed
mutant C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi is
characterized by the amino acid substitution (purFK348Q),
supposed to affect the regulatory key enzyme for the de
novo synthesis. In addition, the mutant exhibits gene dele-
tions for the initiating reaction of glycolysis (pgi) and for
the converting reactions leading from IMP to the succes-
sive purine nucleotides AMP (purA) and GMP (guaB2).
The biomass yield of 0.076 gCDW mmolglucose
-1 for
C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi was con-
sistent with those obtained for C. glutamicum ΔpurA
ΔguaB2 and C. glutamicum ΔguaB2. However, the spe-
cific growth rate was reduced to 0.146 h-1. In contrast to
the two single gene deletion mutants (ΔpurA and
ΔguaB2), the previously observed IMP decline observed
in the double deletion mutant C. glutamicum ΔpurA
ΔguaB2 was even more pronounced in the mutant con-
taining the four genetic modifications (Table 1). In con-
junction with these findings, an increased IMP degradation
towards the corresponding nucleoside inosine and nucleo-
base hypoxanthine was observed.
Quantification of intracellular carbon flux distributions
Alterations of in vivo carbon flux distributions were
investigated in order to assess the impact on the purine
intermediate profile. The network contained reactions of
glycolysis, TCA cycle, anaplerosis and PPP. Estimation
of intracellular flux distributions was carried out based
on measurable extracellular rates, i.e. glucose consump-
tion, biomass and by-product formation as well as the
mass isotopomer data obtained from 13C enriched cellu-
lar protein. Initial values were statistically varied and
multiple parameter estimations were performed to guar-
antee finding of the global minimum solution.
The metabolic carbon flux distributions determined
for the strains C. glutamicum ATCC 13032 (wild type)
and C. glutamicum Δpgi, C. glutamicum ΔpurA ΔguaB2
and C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi are
illustrated in Figure 2. Metabolic and isotopic steadystate was validated for all strains analyzed by 13C MFA.
Metabolic steady state was assessed by constant biomass
and product yields (Table 2), constant intracellular me-
tabolite concentrations (Table 1) and exponential growth
(Table 2). Isotopic steady state was assured comparing
mass isotopomer distributions of amino acids for two
biomass concentrations. Mass isotopomer fractions of
derivatized alanine, glycine, valine, threonine, phenyl-
alanine and serine – determined for C. glutamicum
ATCC 13032 (wild type) – are highlighted as illustrative
examples in Figure 3. Isotopic steady states for
C. glutamicum Δpgi, C. glutamicum ΔpurA ΔguaB2 and
C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi were
assured likewise and exhibited comparable results (data
not shown).
Deletion of the pgi gene strongly affected the car-
bon flux distribution and caused a complete carbon
redirection towards the PPP. The reflux of ribose 5-
phosphate via the non-oxidative part of the PPP
entering glycolysis was almost tripled. Activity of the
TCA cycle was only slightly affected, showing a small
reduction from 47.3% in the wild type strain to 45.7% in
the pgi deletion mutant.
In contrast, the double deletion mutant C. glutamicum
ΔpurA ΔguaB2, possessing an intact pgi gene, exhibited
the lowest flux through the oxidative part of the PPP
(29.3%), which almost exclusively accounted for biomass
formation. The relative reflux into glycolysis was less than
10%. TCA cycle activity was increased to 88%. The strain
C. glutamicum ΔpurA ΔguaB2 purFK348QΔpgi showed a
carbon flux redirection from glycolysis towards the PPP
(98.0%) caused by the pgi gene deletion.Perturbation-caused alterations of the NADH metabolism
The inserted genetic changes also altered the redox
metabolism, especially regarding the NADH/FADH2
(XADH) supply. A surplus was detected in all strains
investigated, which could be used for ATP generation by
oxidative phosphorylation. However, the relative NADH
production exhibited significant differences among the
modified strains (Figure 4): C. glutamicum ATCC 13032
produced a XADH surplus of 369% which decreased to
346% in the pgi deletion mutant. An increased surplus
of 538% was determined for C. glutamicum ΔpurA
ΔguaB2. This difference can be ascribed to the low activ-
ity of the PPP (29%) and the contrariwise high TCA
cycle activity (88%). In comparison to C. glutamicum
ΔpurA ΔguaB2, C. glutamicum ΔpurA ΔguaB2
purFK348Q Δpgi exhibited a decreased XADH surplus of
458.2%.
The consequences of the unequal NADH/FADH2
supply are discussed in more detail in “Cluster analysis”
(see section Discussion).
Figure 2 Intracellular carbon flux distributions with corresponding standard deviations of the central metabolism of the wild type
C. glutamicum ATCC 13032 (in bold) and mutant strains C. glutamicum Δpgi, C. glutamicum ΔpurA ΔguaB2 and C. glutamicum ΔpurA
ΔguaB2 purFK348Q Δpgi (displayed in that order from top to bottom). Net fluxes are given as molar percentage of the mean specific glucose
uptake rates (4.67 mmol g-1 h-1 for C. glutamicum ATCC 13032; 4.18 mmol g-1 h-1 for C. glutamicum Δpgi; 4.24 mmol g-1 h-1 for C. glutamicum
ΔpurA ΔguaB2; 1.92 mmol g-1 h-1 for C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi), which were set to 100%. Anabolic fluxes leading towards
biomass formation were not displayed for the benefit of lucidity. Anabolic demands for auxtrophic mutant strains C. glutamicum ΔpurA ΔguaB2
and C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi were corrected for the supplementation of adenine and guanine. Abbreviations: G6P, glucose
6-phosphate, P5P, pentose 5-phosphate; F6P, fructose 6-phosphate; F16BP, fructose 1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; GAP,
glyceraldehyde 3-phosphate; 3PG, 3-phosphoglycerate; PEP, phosphoenolpyruvate; Pyr, pyruvate; AcCoA, acetyl-CoA; Iso, isocitrate; AKG,
α-ketoglutarate; Suc, succinate; OAA, oxaloacetate; Mal, malate; Glyex, extracellular glycine; Treex, extracellular trehalose.
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Figure 3 Mass isotope fractions [%] of amino acid [M-57] fragments derived from different precursor molecules throughout the central
carbon metabolism. Data are shown exemplarily for C. glutamicum ATCC 13032.
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Rerouting metabolic fluxes – contributions of individual
pathway branches with respect to purine accumulation
Targeted perturbations in the purine biosynthetic pathway
Imbalances in free intracellular purine pools are reported
to be mutagenic and genotoxic [20,21]. Thus a prerequis-
ite for balanced cellular growth is to maintain the intra-
cellular pool sizes, which resulted in efficient regulatory
mechanisms [1,16,17,33,35,38]. This pool stability is on
the one hand sustained by an interaction of de novo pur-
ine synthesis and the salvage pathway, ensuring a con-
stant supply of purine nucleotides required for cellular
growth [16]. On the other hand, increasing concentra-
tions perturbing the system can easily be broken down
via the present degrading and converting reactions.
In case of the purA gene deletion mutant (C. glutamicum
ΔpurA), extracellular supplementation with adenine com-
pletely restored cellular growth, resulting in comparable
specific growth rates of the wild type (0.443 h-1) and theFigure 4 XADH formation for C. glutamicum ATCC 13032,
C. glutamicum Δpgi, C. glutamicum ΔpurA ΔguaB2 and
C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi. Glyceraldehyde
3-phosphate dehydrogenase (GAP-DH), pyruvate dehydrogenase
(Pyr-DH), α-ketoglutarate dehydrogenase (AKG-DH) and malate
dehydrogenase (MAL-DH) were considered as NADH supplying
reactions and succinate dehydrogenase (SUCC-DH) as FADH2
supplying reaction. Anabolically derived NADH was considered
with 3.2 mmol gCDW
-1 [40].C. glutamicum ΔpurA strain (0.455 h-1), indicating a
thorough compensatory effect by the salvage pathway.
On the contrary, extracellular guanine complementation
was not sufficient to restore wild type growth behavior in
the guaB2 gene deletion mutant (C. glutamicum ΔguaB2):
specific growth rate as well as biomass yield were reduced
by 25%, each compared to the wild type strain (Table 2).
This can either be explained by insufficient uptake or
converting systems for guanine. The latter is catalyzed by
the salvage pathway. The observed phenotypic conse-
quences reemerged in every genotype comprising this
genetic perturbation (C. glutamicum ΔguaB2 and C.
glutamicum ΔpurA ΔguaB2), no matter if single or
multiple genes were deleted. The attribution of this
fundamental salvage branch restriction regarding uptake
or conversion could not be answered definitely in this
study. Decreasing intracellular guanine concentrations in
C. glutamicum ΔguaB2, however indicate an uptake insuf-
ficiency (and not a conversion insufficiency!). Decreasing
metabolite concentrations are caused by increased con-
suming reactions (in this case by the salvage pathway).
In contrast, the purA gene deletion mutant C. glutami-
cum ΔpurA exhibited increasing adenine concentrations,
supporting a sufficient adenine uptake, even exceeding
converting reactions by the salvage pathway. This theory
is additionally supported by the reduced guanine uptake
(125 μmol gCDW
-1 ) compared to the adenine uptake (243
μmol gCDW
-1 ), indicating basic differences for both
intermediates.
Regarding intracellular pool sizes, the single gene dele-
tion mutants C. glutamicum ΔpurA and C. glutamicum
ΔguaB2 were found to exhibit the most promising rises
in intracellular IMP concentration with maximal IMP
pool sizes of 44.0 and 37.2 μmol gCDW
-1 , respectively.
These associated transient concentration changes
showed no relation to biomass formation and resulted in
unstable and thus unrepresentative results. This
phenomenon may at least partially be associated with
direct changes in the GMP and AMP pool sizes (Table 1).
These two compounds are reported to act as the most
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by a feedback-mediated inhibition of the PurF enzyme
[16]. With both intermediates operating as regulators, it
is not surprising that the individual gene deletions
cause spreading influences on the whole branching
pathway.
Targeted perturbation in the central carbon metabolism
Increasing the precursor supply via the oxidative branch
of the PPP seemed to be a promising route to boost
intracellular purine levels. This strategy has already been
successfully applied for tryptophan production in E. coli
[39] and lysine production in C. glutamicum [40,41],
illustrating positive correlations between enhanced prod-
uctivity and increased PPP activities [42].
Thus, the genetic modification (deletion of the pgi
gene) was implemented into the genome. The resulting
affects on the purine intermediate pool sizes (Table 1)
however, were rather limited compared to those observed
for purA and guaB2 gene deletion strains, indicating the
strong regulation and rigidity of this pathway.
Effects of combined perturbations on intracellular purine
pool sizes
Strains used for industrial manufacturing of purine
intermediates are usually characterized by an adenine
auxotrophy [35,37,43-45]. This perturbation seems to be
fundamental, revealing the importance of an IMP con-
version block for the accumulation of this intermediate
metabolite [46]. The extracellular supplementation with
adenine, however, is linked to a repression of transcrip-
tion initiation [37] of the genes of the pur operon [37]
via the depletion of PRPP as described for B. subtilis. In
order to counterbalance this phenomenon, the carbon
flux was rerouted by introducing the pgi gene deletion,
aiming at an increased PRPP supply (Figure 2).
The carbon flux was successfully rerouted. Intracellu-
lar purine levels though further shifted from nucleotides
towards their degradation products, mainly inosine and
hypoxanthine (Table 1).
Cluster analysis
In order to analyze correlations between the different
manipulated pathway branches, principal component
analysis (PCA) was performed. The result of the cluster
analysis is illustrated in Figure 5. Pareto-scaled concen-
trations of purine pathway intermediates were used for
the PCA, resulting in the global purine metabolite
phenotype for each mutant.
The first two components contributed to more than
90% of the total variance. As shown in the score plot, a
distinct separation pattern defining two groups could be
derived (Figure 5). The first group (A.), comprising the
wild type strain, the pgi deletion strain and the purFsubstituent, did not show any significant differences con-
cerning intracellular purine intermediate pool sizes. As
discussed earlier, only minor changes with respect to
intracellular concentration of purine pathway intermedi-
ates were caused by these genetic manipulations, which
in direct comparison to the second group (B.) were quite
consistent. The second group (B.), however, resulted in a
broader clustering pattern comprising intrinsic dissimi-
larities. As shown by loading coefficients (Figure 6), the
separation was mainly caused by the component IMP
and its degradation product hypoxanthine, reflecting the
observed shift from nucleotide accumulation towards
increased degradation.
The disruption of critical nodes in the purine pathway
itself, i.e. the conversion of IMP to AMP and GMP, pro-
vided the required fundamental basis for far-reaching
effects when combined with additional modifications as
the pgi gene deletion.
Solely based on the metabolome data, no clear link be-
tween the additional genetic manipulation of the pgi de-
letion and the increased degradation shift could be
concluded. Therefore, the research was extended by an
in-depth fluxome analysis to capture integrative effects
of fluxome and metabolome.Connectivity of targeted metabolome and fluxome
analysis
In the context of purine accumulation, alterations in the
PPP-TCA cycle ratio were of special interest, as their
relative activities and especially the flux partitioning into
these two main branches, mainly dictate the XADH
(NADH+FADH2) supply and thus ATP formation in the
respiratory chain [47]. The exclusive metabolization of
glucose 6-phosphate via the PPP caused a major carbon
flux redistribution in C. glutamicum ΔpurA ΔguaB2
purFK348Q Δpgi, exhibiting an adverse effect on XADH
formation compared to C. glutamicum ΔpurA ΔguaB2
(Figure 4) and initiating a shift in the metabolic profile
towards inosine and especially hypoxanthine formation.
Since most XADH is generated in the TCA cycle, high
PPP activities inevitable lead to an increased CO2 pro-
duction via a decarboxylation reaction in the oxidative
part of the PPP and thus to a reduced carbon availability
for other metabolic branches, as seen for C. glutamicum
ΔpurA ΔguaB2 purFK348Q Δpgi (Figure 2). Within the
scope of the tightly regulated purine biosynthesis, Noguchi
et al. [47] presumed a connection between a declining
ATP supply and an increasing degrading efficiency within
this pathway. The results obtained in this study are con-
sistent with those obtained previously [47].
This suggests further metabolic engineering targets to in-
crease intracellular IMP levels focusing on IMP degrading
reactions.
Figure 5 PCA score plots of principal components 1 and 2 for C. glutamicum ATCC 13032, C. glutamicum Δpgi, C. glutamicum
purFK348Q, C. glutamicum ΔpurA, C. glutamicum ΔguaB2, C. glutamicum ΔpurA ΔguaB2 and C. glutamicum ΔpurA ΔguaB2 purFK348Q
Δpgi. The metabolite profiling was performed using cell extracts of exponentially growing cultures (n = 4 for each strain). The respective seven
strains are shown with corresponding 95% confidence intervals. Data were pareto scaled. The gray insert depicts
the analysis of C. glutamicum ATCC 13032, C. glutamicum Δpgi and C. glutamicum purFK348Q (zoomed from the right lower corner).
For C. glutamicum ΔpurA and C. glutamicum ΔguaB2, data obtained for phase 2 were considered (see Table 1).
Figure 6 Loading coefficients for the first (A.) and second (B.) principal component obtained from multivariate analysis (Figure 5).
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In the present study, we performed an in-depth meta-
bolic profiling of the purine biosynthetic pathway in C.
glutamicum. Site-directed perturbations on the genetic
level with subsequent studies of growth behavior and
targeted metabolome analysis revealed a tight regulation
of the underlying pathway with strong additional effects
on the carbon flux distributions in the main metabol-
ism as determined for C. glutamicum ΔpurA ΔguaB2
and C. glutamicum ΔpurA ΔguaB2 purFK348Q Δpgi.
Our results underline the importance of combined
analyses employing different hierarchical levels such as
fluxome and metabolome to reveal trends which indicate
active regulation mechanism. The regulatory processes
maintaining balanced intracellular concentrations have
not been fully discovered yet and necessitate further in-
vestigation. Complex future studies will thus focus on
the redox and energy metabolism, which were beyond
the scope of the present analyses. In addition, it might
be interesting to further analyze the metabolic instabil-
ities – detected for C. glutamicum ΔpurA and C. gluta-
micum ΔguaB2. These instabilities were caused by the
alteration of the complex regulatory structure of this
pathway branch, opening up a way for in-depth surveys
of this central and essential pathway in prokaryotes as
well as in eukaryotes.
In order to achieve an understanding of the global
cellular response, individual parts of the underlying
network, i.e. precursor and cofactor supply, energy and
redox metabolism, should not be assumed as inde-
pendent, individual but interconnected units, linked by
various key metabolites such as ATP or NAD(P)H.
Methods
Organisms and plasmids
Wild type C. glutamicum ATCC 13032 was obtained from
the American Type Culture Collection (Manassas, VA,
USA) and used as parent strain for further genetic modifi-
cations. E. coli DH5α was utilized as host strain for cloning
and plasmid construction. E. coli NM522pTC served as host
for plasmid amplification and coryne-specific methylation.
The pTC plasmid, harboring an origin of replication for
E. coli (ori), a tetracycline resistance (TetR) as selection
marker and the DNA-methyltransferase gene from C.
glutamicum, was co-expressed in E. coli NM522pTC to
transfer the methylation pattern of C. glutamicum to the
integrative plasmids. The vector pClik was used for inte-
grative genetic modifications. The modifications con-
structed in this study comprised single gene deletions
(ΔpurA, ΔguaB2 and Δpgi), an allelic replacement of the
purF gene encoding amidophosphoribosyltranferase with
a purFK348Q gene (purFK348Q) and multiple gene dele-
tions (ΔpurA ΔguaB and ΔpurA ΔguaB2 purFK348Q Δpgi).
The site-directed mutants and corresponding geneticmodifications are summarized in Table 3. Allelic replace-
ment of the modified purF gene was carried out by first
deleting the native gene followed by a replacement step
with the manipulated gene containing the point muta-
tion. Primer sequences used for construction and verifi-
cation are listed in Table 4.
DNA preparation and recombinant DNA modifications
Oligonucleotide synthesis was performed by Sigma-
Aldrich (Steinheim, Germany) and DNA sequencing was
carried out by GATC (Konstanz, Germany). Plasmid con-
struction and DNA purification were performed using
standard techniques. Preparation of genomic DNA from
C. glutamicum was carried out with the MasterPureTM
Gram Positive DNA Purification Kit (Biozym Scientific
GmbH, Germany). PCR reactions were performed in a
TGradient-Cycler (Whatman–BiometraR) with Phusion
polymerase (Biozym) for insert construction and Jump-
Start REDTaq Ready Mix (Sigma-Aldrich) for strain verifi-
cation. PCR products were purified using NucleoSpinW
Extract II Kit (Macherey-Nagel, Düren, Germany) and
plasmids using HiYieldW Plasmid Mini Kit (SLG, Gauting,
Germany). Ligations were performed with Fast-LinkTM
DNA Ligation Kit (Epicentre Biotechnologies, Madison,
WI, USA). FastDigestW restriction enzymes were obtained
from Fermentas (St. Leon-Rot, Germany) as well as 10
mM dNTP Mix and 1-kb DNA O’GeneRulerTM.
Transformation
Precultures used for transformation of C. glutamicum,
were grown on BHI++ medium (10 mL in 100 mL baffled
shake flasks) and incubated for 12 h at 30°C. The main
culture in BHI++ medium (80 mL in 1000 mL baffled
shake flasks) was inoculated from exponentially growing
precultures to an optical density OD660nm of 0.2. 400 mg
isonicotinic acid hydrazide, 2.5 g glycine and 0.1 mL
Tween 80 were dissolved in 20 mL H2O, sterilized by
filtration and added to the main culture at an OD660nm
of 0.6. Cells were further incubated until an OD660nm of
0.8 was reached and harvested by centrifugation (7 min,
4000 g, 4°C, Laborfuge 400R, Heraeus, Hanau,
Germany). Cells were washed three times with pre-
cooled wash buffer (10% glycerine, 8 mM tris hydro-
chloride, pH 7.4) and once with 10% glycerine. After the
second resuspension in 6 mL 10% glycerine, 200 μL cells
were subsequently used for transformation. Electropor-
ation was performed using a BioRad Gene Pulser II
(Hercules, California, USA) with the following para-
meters: 25 μF, 600 Ω and 2.5 kV. Cells were transferred
into a 2 mL Eppendorf tube, mixed with 1 mL BHIS
medium, followed by a heat shock for 5 min at 46°C. Re-
generation was performed for 90 min at 30°C to allow
recovery of the cells, which were then spread on BHIS-
Kan agar plates and incubated for 4 days.
Table 3 Genetically modified organisms constructed in the present study: Mutant strains of C. glutamicum based on
the wild type strain (ATCC 13032) were constructed by site-directed mutagenesis
Strain Genotype Reference
C. glutamicum ATCC 13032 wild type American Type
Culture Collection
C. glutamicum Δpgi deletion of the pgi gene (NCgl0817) This work
C. glutamicum ΔpurA deletion of the purA gene (NCgl2669) This work
C. glutamicum ΔguaB2 deletion of the guaB2 gene (NCgl0578) This work
C. glutamicum purFK348Q Nucleotide exchange K348Q in the purF gene (NCgl2495) This work
C. glutamicum ΔpurA ΔguaB2 double deletion of purA and guaB2 genes This work
C. glutamicum ΔpurA ΔguaB2
purF348 Δpgi
deletion of purA, guaB2 and pgi genes and allelic amino acid
substitution K348Q in the purF gene
This work
E. coli DH5α F−endA1, hsdR17(rk−mk+) supE44, thi-1λ− recAI gyrA96 relA1 Φ80ΔlacAm15 [48]
E. coli NM522pTC supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5 (rK− mK+) [F0 proAB lacIqZΔM15] Stratagene
E. coli strains were employed for plasmid construction.
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performed as described by Inoue et al. [49]. Transform-
ation of E. coli DH5α and NM522pTC with the integrative
pClik-derivates was performed by heat shock [49]. Briefly,
cells were incubated on ice for 30 min, heated at 45°C for
45 s and again cooled on ice for 2 min. Regeneration was
performed for 1 h at 37°C after 900 μL SOC medium were
added.Targeted mutant generation
Site-directed mutations were introduced using the inte-
grative vector pClik, which lacks an ori for C. glutami-
cum. Selection on KanR as resistance marker yielded
transformed cells with genome-integrated plasmid DNA.
The insertion of the plasmids thereby results from a sin-
gle crossover recombinant event. The second homolo-













a For the single amino acid substitution in purFK348Q, sequences for fusion primers (positive selection system [50], causes the deletion of the
sacB gene and therefore allows growth on correspond-
ing selective agar plates. Due to the sacB associated
additional deletion of the native or the modified gene
sequence, transformants either contain the wild type
gene sequence or exhibit the targeted mutation. KanR-
nonresistant and sucrose-insensitive clones were fur-
ther verified by allelic-specific PCR for the presence of
the targeted gene sequence. The corresponding gene se-
quence for a nucleotide exchange, i.e. purFK348Q, was first
deleted and then replaced.Chemicals
Yeats extract, beef extract, polypeptone, casamino acids,
and brain heart infusion (BHI) were purchased from
Difco Laboratories (Detroit, USA). 99% enriched glucose,












K348Q-1, K348Q-2) containing the point mutation (underlined) are denoted.
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All other chemicals and reagents of analytical grade were
purchased from Sigma-Aldrich, Merck (Darmstadt,
Germany), Fluka (Buchs, Switzerland) or Roth (Karlsruhe,
Germany).Growth Media
The first precultures were grown on complex media (pH
6.8) containing per liter: 10.0 g glucose, 2.5 g NaCl, 2.0 g
urea, 5.0 g yeast extract, 5.0 g beef extract, 5.0 g poly-
peptone and 20.0 g casamino acids. For agar plates, the
complex medium was supplemented with 20.0 g L-1
agar. Second precultures and main cultures were grown
on minimal medium (pH 7.2) containing per liter: 15.0 g
glucose, 4.0 g KH2PO4, 16.0 g Na2HPO4, 500 mg MgCl2 ·
6H2O, 300 mg 3,4-dihydroxibenzoic acid, 100 mg CaCl2 ·
2H2O, 100 μg cyanocobalamin, 750 μg thiamine, 4 μg
pyridoxal phosphate, 100 μg biotin, 400 μg calcium
pantothenate, 2 μg folic acid, 400 μg nicotinic acid, 200
μg 4-aminobenzoic acid, 400 μg pyridoxine · HCl, 2 mg
inositol, 10 mg FeCl2 · 4H2O, 1 mg ZnCl2, 100 μg CuCl2,
20 μg NiCl2 · 6H2O, 20 μg Na2MoO4 · 2H2O, 500 μg
boric acid, 100 μg KI, 100 μg CoCl2 · 6H2O and 10 mg
MnCl2 · 4H2O. For tracer studies, naturally labeled
glucose was replaced by 99% 13C enriched [1-13C] or
[1,2-13C] glucose. Mutants of C. glutamicum exhibiting
deletions of adenylosuccinate synthetase (purA) or IMP
dehydrogenase (guaB2) were grown on minimal media
additionally supplemented with 200 mg L-1 adenine
sulfate or 80 mg L-1 guanine hydrochloride, due to the
introduced auxotrophies.
Media used for transformation experiments of C. glu-
tamicum contained per liter: 37 g BHI, 26.4 g (NH4)
2SO4 and 40 g glucose for BHI
++ and 37 g BHI and 46 g
sorbitol for BHIS medium.Cultivations
Cultivations were carried out in baffled shake flasks on
an orbital shaker (Multitron 2, Infors AG, Bottmingen,
Switzerland) at 230 rpm and 30°C. First precultures were
grown on complex medium (25 mL medium in 250 mL
baffled flask) for 8 h and used for inoculation of the sec-
ond precultures (25 mL medium in 250 mL baffled
flask). Second precultures and main cultures were per-
formed in minimal medium. Main cultivations were per-
formed in duplicates in minimal medium using 500 mL
baffled shake flasks with 50 mL medium. For tracer
experiments, which were conducted under the same
conditions as main cultivations, naturally labeled glucose
was replaced by [1-13C] glucose or [1,2-13C2] glucose for
analysis of glucose 6-phosphate isomerase (pgi) deletion
mutants and the volume was adjusted to 5 mL in 50 mL
baffled shake flasks.Substrate and product analysis
Biomass concentration was determined by measuring the
optical density of the culture at 660 nm (OD660nm) using a
photometer (Marsha Pharmacia Biotech, Freiburg,
Germany) which was gravimetrically correlated with the
cell dry weight The correlation factor was determined as
0.414 gCDW OD660nm
-1 . Extracellular substrates and secreted
products were analyzed after 3 min centrifugation at
16,000 g. Quantification of glucose, α-ketoglutarate and
trehalose was performed in diluted supernatants by HPLC
(Kontron Instruments, Neufahrn, Germany). Separation
was performed using an Aminex HPX-87H Bio-Rad
column (300 x 7.8 mm; Hercules, USA), at 55°C with a
constant flow rate of 0.8 mL min-1 (7 mM H2SO4 as mo-
bile phase). Refraction index (RI) detection was used for
quantification of sugars, and UV detection at 218 nm for
organic acids and at 254 nm for quantification of supple-
mented adenine and guanine. Determination of amino
acids was performed as described previously [36]. Extra-
cellular concentrations of adenine and guanine were
determined by HPLC (Agilent 1290 Infinity; Agilent Tech-
nologies, Waldbronn, Germany) using a Phenomenex
(Aschaffenburg, Germany) reversed-phase C18-column
(Gemini 5u 110Å, 150 x 4.6 mm). Separations were car-
ried out at 10°C with a constant flow of 0.8 mL min-1.
Gradient elution was performed using 5 mM ammonium
formate solution at pH 5.8 (eluent A) and acetonitrile:
methanol:water mixture (45:45:10, eluent B) applying the
following gradient: an initial isocratic step with 0% B (3.5
min) was followed by an increase to 30% within 10 min
and to 100% within 1 min. The flushing step at 100% B
was performed for 5 min. The column was reconditioned
at 0% B for another 5 min.Analysis of intracellular metabolites
Extraction and quantification of intracellular purine
intermediates, i.e. nucleotides, nucleosides and nucleo-
bases, by LC-ESI-MS/MS was performed as described
previously [28].Mass spectrometric 13C-labeling analysis
The mass isotopomer distributions of amino acids derived
from cellular protein and of trehalose secreted during cul-
tivation were determined by mass spectrometry–gas chro-
matography. Sample preparation and instrument settings
were performed as described previously [41,51,52]. In
order to ensure isotopic steady state, labeling patterns of
amino acids and trehalose were determined for two bio-
mass concentrations during mid-exponential growth.
Metabolic (pseudo-) steady state was assessed by constant
yields, uptake and secretion rates and constant intracellu-
lar pool sizes of purine intermediates.
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Calculation of the in vivo metabolic fluxes of the C. glu-
tamicum strains was carried out by fitting simulated
mass isotopomer distributions to experimentally deter-
mined labeling patterns of amino acids derived from cel-
lular protein and trehalose secreted during cultivation.
The calculations were based on the approach of Yang
et al. [53] implemented in Matlab (version 2008b, Math-
works Inc., Nattick, USA) using metabolite and isotopo-
mer balancing. Anabolic demands for biomass synthesis
and extracellular production rates ware additionally con-
sidered [54] and implemented in the metabolic network.
Media supplementation with adenine and guanine –
required by strains comprising adenylosuccinate synthe-
tase and/or IMP dehydrogenase deletions – led to
reduced anabolic demands for DNA and RNA syntheses.
The corresponding reduced anabolic demand for 3-
phosphoglycerate was considered. In addition, increased
ribose 5-phosphate requirements due to increased intra-
cellular pool sizes of IMP, determined for C. glutamicum
ΔpurA ΔguaB2 purFK348Q Δpgi and C. glutamicum
ΔpurA ΔguaB2, were considered likewise.
Measured GC-MS data were corrected for naturally
occurring isotopes in the corresponding amino acid frag-
ments and derivatization reagent respectively [55,56]. A
Monte Carlo approach with 100 independent runs was
employed for the statistical analysis [57].Data analysis
Mean concentration values for purine intermediates
were calculated from four biological replicates for each
strain for two biomass concentrations and corrected
using 13C-labeled cell extract as internal standard as
described previously [28]. The metabolomics-based
phenotype profiling was extended by principal compo-
nent analysis (PCA) applying pareto scaling of the data.
Data sets were compressed by reduction of dimension
numbers and the metabolomic patterns were high-
lighted. PCA was performed using Matlab R2007b (The
Math Works, Inc., Boston, USA) software.Competing interests
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